The Food and Drug Administration approved on Friday a new medicine from BridgeBio for patients with a progressive heart ...

Oral peptide with biologics-like high potency and spectrum of activity against three therapeutically relevant dimeric forms of IL-17 (AA, AF and ...

The novel IL-17A and IL-17F inhibitor has been approved for moderate to severe hidradenitis suppurativa, a chronic and ...

This approval is the fifth overall for bimekizumab (Bimzelyx; UCB Pharma) in the US, and they all have come in the last 13 ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

Cardiac contractility modulation therapy is a relatively new, FDA-approved heart failure treatment proven to improve quality ...

The UK’s National Health Service (NHS) is rolling out a free antismoking pill called varenicline for British smokers. Research has shown that varenicline is more effective than traditional ...

President-elect Trump’s decision to nominate Robert F. Kennedy Jr. for Health and Human Services (HHS) secretary will put some of the former independent presidential candidate’s most ...

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

A delay in the FDA decision for NT-501 could leave those with macular telangiectasia (MacTel) without any form of treatment ...

Total Revenues in the first nine months of 2024 increased by $300 million compared to same period in 2023, to $339 million, with Q3 revenues contributing $103 millionProduct revenues in the first nine ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Greetings, and welcome to the Kamada Ltd. Third Quarter 2024 ...